Should empiric therapies be used for male factor infertility?

Fertile Battle

Editorial Office, American Society for Reproductive Medicine

Published Jun 17, 2020

Volume 113, Issue 6, Pages 1121–1130

Authors:

Kai J. Buhling, M.D., Peter Chan, M.D., Martin Kathrins, M.D., Marian Showell, M.P.H., M.L.I.S., Sarah C. Vij, M.D., Mark Sigman, M.D.

Abstract:

PRO: Empiric therapies should be used for male factor infertility

CON: Empiric therapies should not be used for male factor infertility

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.

Should empiric therapies be used for male factor infertility?

Share

Volume 113, Issue 6, Pages 1121–1130

Authors:

Abstract:

Fertility and Sterility

You may also be interested in...

Intramural myomas more than 3–4 centimeters should be surgically removed before in vitro fertilization

Surgical treatment of uterine septum to improve reproductive outcomes — resect or not?

Should women undergoing in vitro fertilization treatment or who are in the first trimester of pregnancy be vaccinated immediately against COVID-19

Reproductive Endocrinology and Infertility fellowship programs: Does one size fit all?

Cookies